Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.

News | Stents

Biotronik's Orsiro Stent Continues Excellent Results After Three Years

February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the ...

February 24, 2020

A 3-D rendering created from the chest CT scan of a 41-year-old coronavirus patient in China showing ground-glass opacities in several areas of the lungs from the coronavirus pneumonia. This was from one of the first medical imaging studies published on COVID-19 in the journal Radiology. #coronavirus #COVID2019 #COVID19 #2019nCoV #SARS‐CoV‐2

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

The Cardiac Implications of Novel Coronavirus

(Article updated May 27, 2020)

February 20, 2020 — The American College of Cardiology (ACC) released a clinical ...

February 20, 2020

The DEFINE GPS (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) study will be the first time that the use of iFR in conjunction with the Philips Image-Guided Co-registration System (SyncVision) is evaluated for PCI guidance and the optimization of treatment outcomes.

News | Cath Lab Navigation Aids

DEFINE GPS Study Assesses PCI Guided by Integrated iFR and Angiography

February 12. 2020 — Philips announced a new randomized controlled trial to assess patient outcomes after receiving a ...

February 12, 2020

Videos | Hemodynamic Support Devices

VIDEO: Door-to-Unloading (DTU) Trial May Change STEMI Care

Interview with Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and ...

February 07, 2020

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system, left, became the first TMVR device to gain commercial regulatory clearance in the world. It gains European CE mark in January. Another top story in January was the first use of the Robocath R-One robotic cath lab catheter guidance system in Germany. Watch a VIDEO of the system in use in one of those cases.

News | Dave Fornell, Editor

February 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...

February 03, 2020

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive heart valve replacement to open-heart surgery. Photo by Cedars-Sinai. TAVR performs as well as surgery for aortic valve replacement.

News | Heart Valve Technology

January 31, 2020 — A new study from the Smidt Heart Institute at Cedars-Sinai and other centers nationwide shows that ...

January 31, 2020

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies

Scientists Image Heart RNA Structure for the First Time

January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special ...

January 20, 2020

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. She was a patient at the DMC Sinai-Grace Hospital in Detroit.

News | Cardiac Rehabilitation

Only 1 in 4 Medicare Patients Participate in Cardiac Rehabilitation

January 15, 2020 – Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart ...

January 15, 2020

This is the latest version of the MitraClip, the G4, which allows each side of the clip to be opened and closed independently to offer more flexibility when capturing the valve leaflets. The device is being used in the REPAIR MR clinical trial.

News | Heart Valve Technology

New Study Looks at MitraClip use in Moderate Surgical Risk Patients

January 13, 2020 — The U.S. Food and Drug Administration (FDA) has approved clinical trial that will compare the ...

January 13, 2020

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

News | Cath Lab | Dave Fornell, Editor

EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdre ...

January 02, 2020

Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)

News | Cardiovascular Clinical Studies

Top Cardiology News in 2019 From the European Society of Cardiology (ESC)

Environmental and lifestyle issues were popular this year, with pick up from both European Society of Cardiology (ESC) j ...

December 23, 2019

Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.

Feature | Pharmaceuticals | Dave Fornell, Editor

FDA Expands Vascepa to Reduce Cardiovascular Events in Elevated Triglyceride Patients

December 16, 2019 — The U.S. Food and Drug Administration (FDA), on Dec. 13, approved the use of Vascepa (icosapent ...

December 16, 2019

A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.

News | Heart Valve Technology | Dave Fornell, Editor

TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study

November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...

November 26, 2019

News | Cardiovascular Clinical Studies

Virtual Study to Track Statin-Related Adverse Events Being Undertaken by University of Connecticut and Hartford Healthcare

November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have ...

November 26, 2019

News | AHA

Weekend Sudden Cardiac Arrests are More Deadly

November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be ...

November 21, 2019